Apr 23, 2020
In Silico/Computer-Aided Drug Discovery Services Market, 2020-2030 - Key Step(s) of Drug Discovery, Types of Large Molecules, Company Sizes, Therapeutic Areas, Types of Clientele, Key Regions
Mar 19, 2020
PolarisQB and Fujitsu announce pioneering drug discovery platform to speed up the process of bringing new drugs to market
Nov 11, 2019
BioTheryX, Inc. Announces the Appointment of BioPharma Finance Veteran Peter N. Crnkovich to Board of Directors
Aug 23, 2019
HotSpot Therapeutics Announces Acquisition of Macroceutics, Inc.
Jul 11, 2019
Global Small Molecule CMO Market to 2023 - Robust Pipeline of Small Molecule Drugs and Increasing Rate of FDA Approvals
Mar 19, 2019
Alcami Kickstarts Biologics Enterprise to Advance Treatments for Complex Medical Conditions
Dec 18, 2018
DelSiTech and Innovare Sign Licensing Agreement for the Development of a Long Acting HIV Therapy
Dec 05, 2018
Mary Crivellone, PhD, Former Director of Global Laboratory Integration at USP, Joins NDA Partners as an Expert Consultant
Dec 04, 2018
Integral Molecular's Therapeutic MAbs Against CB1 to Treat NASH Enter New Development Phase Following $1.4M NIH Award
Nov 26, 2018
Global Biologics Drug Development Market: Focus on Facility, Service, Product Type, Country Analysis, and Market Dynamics - Analysis and Forecast, 2018-2027
Aug 16, 2018
Global Oral Proteins and Peptides Market to 2030
Jul 23, 2018
Anima Biotech Announces an Exclusive Collaboration With Lilly for the Discovery and Development of Translation Inhibitors of Several Protein Targets
Jul 17, 2018
HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discovery
Jun 27, 2018
LUMICKS Collaborates with AstraZeneca and the University of Cambridge to Form the First Ever Center of Excellence for Dynamic Single-Molecule Analysis for Accelerated Drug Discovery and Biology
May 08, 2018
Oral Proteins and Peptides Market (3rd Edition), 2018-2030
Dec 14, 2017
Antibacterial Drugs Market Value to Reach US$51,447.6 Million by the End of 2025: Transparency Market Research
Aug 04, 2017
Tokyo Institute of Technology and Kawasaki City are Combining Forces in R&D on Computational Drug Discovery for Middle Molecules at Kawasaki KING SKYFRONT